Anupam Rasayan India Ltd Stock

Stocks

ANURAS

INE930P01018

Specialty Chemicals

Valuation: Anupam Rasayan India Ltd

Market Cap 134B 1.4B 1.23B 1.17B 1.06B 1.99B 2.02B 14B 5.39B 68.74B 5.27B 5.15B 220B P/E 2027 *
46.4x
P/E 2028 * 29.6x
Enterprise Value 151B 1.57B 1.38B 1.31B 1.18B 2.23B 2.26B 15.68B 6.03B 76.98B 5.9B 5.77B 247B EV / Sales 2027 *
4.41x
EV / Sales 2028 * 3.39x
Free-Float
16.06%
Yield 2027 *
0.18%
Yield 2028 * 0.28%
09-27 Anupam Rasayan India Ltd completed the acquisition of an additional 43.30% stake in Bliss GVS Pharma Limited from Shruti Vishal Rao, Vibha Gagan Sharma, Narsimha Shibroor Kamath, Gautam Rasiklal Ashra, Arjun Gautam Ashra and Gulbarga Trading and Investment Private Limited. CI
09-19 Anupam Rasayan India Limited Approves Issuance Of INR 1,600 Million Secured Rated Unlisted Redeemable Non-Convertible Debentures On Private Placement Basis CI
09-08 Tanfac Industries Limited announced that it has received INR 994.098627 million in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited and other investor. CI
09-07 Anupam Rasayan India Ltd Appoints Hetvi Vyas, as Deputy Chief Financial Officer and Key Managerial Personnel CI
09-05 Anupam Rasayan India Limited Secures Chemical Supply Contract With Major Speciality Metal Manufacturer CI
08-15 Anupam Rasayan India Ltd, Q1 2027 Earnings Call, Aug 14, 2026
08-14 Anupam Rasayan India Ltd Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
08-14 Anupam Rasayan India Limited Announces Appointment of Ravi Desai to Chief Operating Officer, Effective August 14, 2026 CI
08-09 Anupam Rasayan India Ltd completed the acquisition of 0.001% stake in Bliss GVS Pharma Limited for INR 0.5 million. CI
07-16 Anupam Rasayan India Ltd acquired Mates Visa Consultancy Private Limited for INR 0.01 million. CI
07-15 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
07-05 Tanfac Industries Limited announced that it expects to receive INR 1.734873 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited and other investor. CI
06-11 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
1 day-1.78%
1 week-1.46%
Current month-1.78%
1 month-7.92%
3 months-8.70%
6 months-9.12%
Current year-12.05%
1 week 1,155
Extreme 1155
1,204
1 month 1,115.8
Extreme 1115.8
1,266.3
Current year 1,115.8
Extreme 1115.8
1,415
1 year 1,047.9
Extreme 1047.9
1,415
3 years 601
Extreme 601
1,415
5 years 546.75
Extreme 546.75
1,415
10 years 474
Extreme 474
1,415
Manager TitleAgeSince
Chief Executive Officer - 2023-09-10
Director of Finance/CFO 36 2022-03-14
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 51 2013-04-22
Director/Board Member 52 1991-12-31
Chairman 77 2020-08-30
Change 5-day change 1-year change 3-year change Capi.($)
-1.91%-1.46%+8.89%+31.94% 1.4B
-1.18%-0.77%+0.26%+62.09% 76.97B
-0.84%-0.56%+5.35%+15.20% 37.73B
-2.16%-1.48%+0.70%-22.00% 35.38B
-1.47%-2.97%+4.23%+6.42% 31.95B
-0.72%-5.96%+5.36%+50.58% 29.7B
+1.34%+0.71%-6.32%+17.69% 25.47B
-0.31%-0.91%+44.12%+32.63% 22.97B
-1.83%-6.09%+50.93%+8.71% 18.53B
-0.18%-0.76%-44.42%-41.95% 17.54B
Average -0.90%-1.56%+6.91%+16.13% 29.77B
Weighted average by Cap. -0.93%-1.34%+5.28%+23.36%

Financials

2027 *2028 *
Net sales 34.12B 356M 313M 297M 268M 505M 512M 3.55B 1.37B 17.44B 1.34B 1.31B 55.93B 43.88B 458M 403M 382M 345M 650M 658M 4.57B 1.76B 22.43B 1.72B 1.68B 71.93B
Net income 2.87B 29.88M 26.32M 24.93M 22.51M 42.42M 42.97M 298M 115M 1.46B 112M 110M 4.7B 4.48B 46.69M 41.11M 38.95M 35.16M 66.28M 67.13M 466M 179M 2.29B 175M 171M 7.34B
Net Debt 16.14B 168M 148M 140M 127M 239M 242M 1.68B 646M 8.25B 632M 618M 26.45B 14.27B 149M 131M 124M 112M 211M 214M 1.49B 572M 7.3B 559M 547M 23.4B
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,501
Date Price Change Volume
26-10-01 ₹1,162.90 -1.53% 133,216
26-09-30 ₹1,181.00 +0.27% 133,965
26-09-29 ₹1,177.80 -0.78% 192,300
26-09-28 ₹1,187.10 -0.44% 194,981
26-09-25 ₹1,192.40 +1.29% 167,982
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,181.00INR
Average target price
1,279.17INR
Spread / Average Target
+8.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANURAS Stock